Abbott has become the first company to secure a CE mark for a continuous glucose-ketone sensor for diabetic patients. Credit: Abbott via PR Newswire. · Medical Device Network · Abbott via PR Newswire.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

First-of-its-kind biowearables combine continuous glucose and ketone monitoring in a single sensor to support both daily diabetes management and help detect rising ketone levels that can lead to ...

Abbott has secured the US Food and Drug Administration (FDA) and CE Mark approvals for its Amplatzer Piccolo delivery system, designed for premature infants diagnosed with patent ductus arteriosus ...

Abbott Laboratories (US0028241000) expands its diabetes franchise in Europe with a new sensor-based innovation. The S&P 500 healthcare group, listed on the NYSE under the ticker ABT, has secured a CE ...

Medtech giant Abbott has secured a CE mark for two of its glucose-ketone sensing systems for diabetic patients, making the devices the first of their kind to reach this milestone. The biowearables, ...

Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™, is designed with dual-energy to treat atrial fibrillation patients with the most challenging cases It can deliver both radiofrequency energy ...